Anupam Rasayan India Ltd (ANURAS.BO)
- Previous Close
1,023.60 - Open
1,023.60 - Bid 1,038.10 x --
- Ask --
- Day's Range
1,023.60 - 1,048.00 - 52 Week Range
600.95 - 1,048.00 - Volume
7,033 - Avg. Volume
20,800 - Market Cap (intraday)
114.559B - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
122.60 - EPS (TTM)
8.50 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield 1.25 (0.12%)
- Ex-Dividend Date Sep 18, 2024
- 1y Target Est
703.00
Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
www.anupamrasayan.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: ANURAS.BO
View MorePerformance Overview: ANURAS.BO
Trailing total returns as of 6/5/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ANURAS.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ANURAS.BO
View MoreValuation Measures
Market Cap
112.53B
Enterprise Value
124.89B
Trailing P/E
120.42
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
7.82
Price/Book (mrq)
3.95
Enterprise Value/Revenue
8.69
Enterprise Value/EBITDA
30.29
Financial Highlights
Profitability and Income Statement
Profit Margin
6.50%
Return on Assets (ttm)
3.78%
Return on Equity (ttm)
5.32%
Revenue (ttm)
14.37B
Net Income Avi to Common (ttm)
933.49M
Diluted EPS (ttm)
8.50
Balance Sheet and Cash Flow
Total Cash (mrq)
1.35B
Total Debt/Equity (mrq)
44.57%
Levered Free Cash Flow (ttm)
-5.78B